Article

Hepatitis B virus genotypes in southwest Iran: molecular, serological and clinical outcomes.

Gastroenterology and Hepatology Research Center, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
World Journal of Gastroenterology (Impact Factor: 2.43). 04/2008; 14(10):1510-3.
Source: PubMed

ABSTRACT To investigate the associations of hepatitis B virus (HBV) genotype with HBeAg and anti-HBe status, alanine aminotransferase (ALT) levels and HBV-DNA detection in different groups of HBV-infected patients in southwest Iran.
A total of 89 HBsAg-positive serum samples were collected from the same number of patients. All sera were then investigated to determine HBV DNA and serological markers. For all the polymerase chain reaction (PCR)-positive samples, biochemical, histopathological assays and genotyping were also performed.
Genotype D was the only type of HBV found in different clinical forms of acute and chronic infections. There was a high prevalence of HBeAg-negative HBV-infected patients with chronic hepatitis (52.7%). Out of 55 patients with chronic hepatitis, seven (12.7%) were diagnosed with cirrhosis. A significant association between the presence of anti-HBe antibody and an increase in ALT level, among either HBeAg-negative (P = 0.01) or HBeAg-positive (P = 0.026) patients, was demonstrated. No significant differences were observed between the clinical outcomes of HBeAg-positive and -negative individuals (P = 0.24).
Genotype D has been recognized as the only type of HBV found in different clinical forms of HBV infections, including cirrhosis, among the residents of southwest Iran. Anti-HBe possibly plays a role in disease progression in some patients with chronic hepatitis, at least for a period of disease.

Download full-text

Full-text

Available from: Mehrzad Banihashemi, Jul 05, 2015
2 Followers
 · 
234 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: High incidence of HCC is mostly due to the combination of two major risk factors, chronic infection with hepatitis B (HBV) and/or C (HCV) viruses and exposure to the mycotoxin aflatoxin B(1), which induces a particular mutation at codon 249 in TP53 (R249S). Eight genotypes of HBV are diversely found in high and low incidence areas. Regardless of documented strong associations between TP53 R249S mutation and HBV genotypes B, C, A or E, there is no report of such association for genotype D despite of the presence of aflatoxin in areas with high prevalence of HBV genotype D. In Iran, 3% of the population is chronically infected with HBV, predominantly genotype D. Twenty-one histologically confirmed HCC cases from Iran were analyzed for TP53 R249S and HBV double mutations 1762(T)/1764(A), hallmarks of more pathogenic forms of HBV. We did not detect any of these mutations. In addition, we report the only case identified so far carrying both R249S mutation and chronic HBV genotype D, a patient from The Gambia in West Africa. This paper suggests that association between HBV genotype D and aflatoxin-induced TP53 mutation is uncommon, explaining the relatively lower incidence of HCC in areas where genotype D is highly prevalent.
    Hepatitis research and treatment 08/2011; 2011:475965. DOI:10.1155/2011/475965
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis B virus (HBV), the prototype member of the family hepadnaviridae, is a human pathogen, causing the serious liver disease. The virus is the major cause of chronic hepatitis cirrhosis, and hepatocellular carcinoma worldwide. HBV has been classified into eight genotypes, which vary in geographic distribution. The aim of this study was to recognize the HBV genotypes in hepatitis B surface antigen (HBsAg)-positive carriers in west of Iran. In this study, one hundred HBsAg-positive carriers were used. Genotypes of HBV were recognized by nested-PCR that combined by restriction fragment length polymorphism (RFLP) technique. Eighty six out of hundred samples were positive-PCR and were used for HBV genotyping. Recognized genotypes were D and B, with frequency of eighty five and one cases (out of eighty six samples) respectively, while no result was obtained in other fourteen samples. This study indicated that predominant genotype of HBV in west of Iran is genotype D, while genotype B is very rare in this region.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To characterize the clinical, serologic and virologic features of hepatitis B virus (HBV) infection in Iranian patients with different stages of liver disease. Sixty two patients comprising of 12 inactive carriers, 30 chronic hepatitis patients, 13 patients with liver cirrhosis and 7 patients with hepatocellular carcinoma (HCC) were enrolled in the study. The HBV S, C and basal core promoter (BCP) regions were amplified and sequenced, and the clinical, serologic, phylogenetic and virologic characteristics were investigated. The study group consisted of 16 HBeAg-positive and 46 HBeAg-negative patients. Anti-HBe-positive patients were older and had higher levels of ALT, ASL and bilirubin compared to HBeAg-positive patients. Phylogenetic analysis revealed that all patients were infected with genotype D (mostly ayw2). The G1896A precore (PC) mutant was detected in 58.1% patients. HBeAg-negative patients showed a higher rate of PC mutant compared to HBeAg-positive patients (c2 = 9.682, P = 0.003). The majority of patients with HCC were HBeAg-negative and were infected with PC mutant variants. There was no significant difference in the occurrence of BCP mutation between the two groups, while the rate of BCP plus PC mutants was higher in HBeAg-negative patients (c2 = 4.308, P = 0.04). In the HBV S region, the genetic variability was low, and the marked substitution was P120T/S, with a rate of 9.7% (n = 6). In conclusion, HBV/D is the predominant genotype in Iran, and the nucleotide variability in the BCP and PC regions may play a role in HBV disease outcome in HBeAg-negative patients.
    World Journal of Gastroenterology 10/2008; 14(35):5448-53. · 2.43 Impact Factor